Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene

Thrombosis Journal

Volumn 4, Issue , 2006, Pages

  Jacobsen, Eva M ^a   Trettenes, Elin J ^b   Wisløff, Finn ^a   Abildgaard, Ulrich ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; HEXADIMETHRINE BROMIDE; LUPUS ANTICOAGULANT; PHOSPHOLIPID; POLYARGININE; POLYLYSINE; PROTAMINE; THROMBOPLASTIN;

ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; HEPARINIZATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PARTIAL THROMBOPLASTIN TIME; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; SERODIAGNOSIS;

EID: 33746379544     PISSN: 14779560     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-4-3     Document Type: Article

References (19)

1. Roubey RAS: Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood 1994, 84:2854-2867.
2. Brandt JT, Triplett DA, Alving B, Scharrer I: Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995, 74:1185-1190.
3. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GRV, Triplett DA, Khamashta MA: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop. Arthritis Rheum 1999, 42:1309-1311.
4. Schjetlein R, Sletnes KE, Wisløff F: A quantitative, semi-automated and computer-assisted test for lupus anticoagulant. Thromb Res 1993, 69:239-250.
5. Jacobsen EM, Barna-Cler L, Taylor JM, Triplett DA, Wisloff F: The Lupus Ratio test - an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semi- quantitative test. Fifth International Survey of Lupus Anticoagulants - ISLA 5. Thromb Haemost 2000, 83:704-708.
6. Liestøl S, Jacobsen EM, Wisløff F: Dilute prothrombin time-based lupus ratio test. Integrated LA testing with recombinant tissue thromboplastin. Thromb Res 2002, 105:177-182.
7. Lawrie AS, Mackie IJ, Purdy G, Machin SJ: The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo - optical and mechanical coagulometers. Thromb Haemost 1999, 81:758-762.
8. Exner T, Hohnen-Behrens C, Newman P, Dargan W: Effect of instruments on lupus anticoagulant testing [letter; comment]. Thromb Haemost 2000, 83:345-348.
9. Machin SJ, Giddings, Greaves M, Hutton RA, Mackie IJ, Malia RG, Taberner DA: Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force. J Clin Pathol 1991, 44:885-889.
10. Jacobsen EM, Sandset PM, Wisløff F: Do antiphospholipid antibodies interfere with tissue factor pathway inhibitor? Thromb Res 1999, 94:213-220.
11. Godal HC: A comparison of two heparin-neutralizing agents: protamine and polybrene. Scan J Clin Lab Invest 1960, 12:446-457.
12. Cumming AM, Jones GR, Wensley RT, Cundall RB: In vitro neutralization of heparin in plasma prior to the activated partial thromboplastin time test: an assessment of four heparin antagonists and two anion exchange resins. Thromb Res 1986, 41:43-56.
13. Fischer A: Die Bindung von Heparin an Eiweiss. Biochem Zeit 1935, 278:133.
14. Chargaff E, Olson KB: Studies on the chemistry of blood coagulation. VI. Studies on the action of heparin and other anticoagulants. The influence of protamine on the anticoagulant effect in vivo. J Biol Chem 1937, 122:153-167.
15. Fabian I, Aronson M: Polycations as possible substitutes for protamine in heparin neutralization. Thromb Res 1980, 17:239-247.
16. Preston FW: The antiheparin effect of Polybrene. (A polymer of N,N,N′,N,-Tetramethylhexamethylenediamine and trimethylene bromide). J Lab Clin Med 1952, 40:927.
17. Jacobsen EM, Barna-Cler L, Taylor JM, Triplett DA, Wisloff F: The evaluation of clotting times in the laboratory detection of lupus anticoagulants. Thromb Res 2001, 104:275-282.
18. Schulman S, Svenungsson E, Granqvist S: Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. Am J Med 1998, 104:332-338.
19. Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, Turpie AG, Green D, Ginsberg JS, Wells P, MacKinnon B, Julian JA: A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. (See comments: N Engl J Med 1999;341:539-40). N Engl J Med 1999, 340:901-907.